NCT00158665View on ClinicalTrials.gov

A Comparison of One Versus Two Doses of Influenza Vaccine in Children 5-8 Years of Age

NACompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Influenza
Interventions
BIOLOGICAL

2 0.5 ml doses of '04-05 Trivalent Influenza Vaccine

2 0.5 ml doses of '04-05 Trivalent Influenza Vaccine

Trial Locations (1)

98101

Group Health Research Institute, Seattle

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Kaiser Permanente

OTHER

NCT00158665 - A Comparison of One Versus Two Doses of Influenza Vaccine in Children 5-8 Years of Age | Biotech Hunter | Biotech Hunter